We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Sues Watson Over Application to Market Generic Cenestin
Teva Sues Watson Over Application to Market Generic Cenestin
May 11, 2010
Teva Women’s Health has filed a patent-infringement suit against Watson Pharmaceuticals in response to the company’s application to make a generic version of Teva’s drug Cenestin for the treatment of menopause symptoms.